BioCentury
ARTICLE | Clinical News

Celgene regulatory update

June 5, 1995 7:00 AM UTC

Celgene Corp. (CELG) The FDA granted Orphan Drug designation for Synovir, CELG's thalidomide compound, to treat recurrent aphthous ulcers (canker sores) in immunocompromised patients. Synovir also ha...